Dr. Michael Lee Sands, MD

Dr. Sands practices at UF Health Jacksonville in Jacksonville, Florida, part of UF Health.

Dr. Sands' NPI, 1902852106, was assigned on May 26, 2006. Dr. Sands graduated from Georgetown University School Of Medicine in 1972. Dr. Sands holds Florida license ME76899.

Dr. Sands' primary practice is UF Health Jacksonville, at 655 W 8th St, Jacksonville, FL 32209 in Duval County. The practice phone is (904) 244-4000.

Dr. Sands' primary practice is UF Health Jacksonville in Jacksonville, Florida, part of UF Health. The medical group on file is UF Jacksonville Physicians, Inc. Dmand AI also links Dr. Sands to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sands practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Sands' primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Sands is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Sands' licenses on file in 6 states: Florida, California, Pennsylvania, Massachusetts, Illinois and Louisiana.

Dmand AI lists hiv/aids and joint or bone infection among the conditions Dr. Sands treats.

CMS data shows 37 Medicare services from Dr. Sands across 2 procedure codes in 2024, for 39 Medicare patients. Medicare paid $2,781 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Dr. Sands in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 3.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sands' median patient age at 61, with 43% women.

In 2024, Dr. Sands wrote 61 Medicare Part D claims. 34% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $51,624 in total drug cost. In 2023, CMS named 42 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 60 out of 100 for Dr. Sands for performance year 2024, reported through an alternative payment model (APM). Dr. Sands accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Sands, published from 2007 to 2022. 2022 was the busiest year, with 3. Dr. Sands has published most often in Cureus. Dr. Sands' most frequent co-authors are Malleswari S. Ravi, MD, Danisha Giselle Figueroa, MD and Okechukwu Nwakile Mgbemena, MD.

CMS Open Payments shows 2 general payments to Dr. Sands from 2 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Intuitive Surgical, Inc. paid the most, $300.

Dr. Sands graduated from Georgetown University School Of Medicine in 1972.

Dr. Sands is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.